Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Receivables (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Receivables data on record, last reported at $415.6 million in Q4 2025.

  • For Q4 2025, Receivables fell 7.57% year-over-year to $415.6 million; the TTM value through Dec 2025 reached $415.6 million, down 7.57%, while the annual FY2025 figure was $415.6 million, 7.57% down from the prior year.
  • Receivables reached $415.6 million in Q4 2025 per AHCO's latest filing, up from $412.5 million in the prior quarter.
  • Across five years, Receivables topped out at $477.3 million in Q2 2024 and bottomed at $274.6 million in Q1 2021.
  • Average Receivables over 5 years is $404.1 million, with a median of $407.8 million recorded in 2023.
  • Peak YoY movement for Receivables: skyrocketed 135.53% in 2021, then dropped 10.58% in 2025.
  • A 5-year view of Receivables shows it stood at $383.7 million in 2021, then increased by 3.66% to $397.7 million in 2022, then grew by 14.98% to $457.3 million in 2023, then fell by 1.68% to $449.6 million in 2024, then decreased by 7.57% to $415.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $415.6 million in Q4 2025, $412.5 million in Q3 2025, and $426.8 million in Q2 2025.